Saturday 17 October 2026
Export NMAD’s income statement to Excel — free account
Nomad Power Solutions, Inc.
NMAD Healthcare Biotechnology
In the quarter to June 2026, EPS grew 44.8% and free cash flow fell 230.6%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
3.88
0.21
−5.13%
Follow NMAD
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(3,661.47%) | (185.41%) | (213.84%) | (68.04%) | |
| (115.96%) | (87.60%) | (118.11%) | (62.67%) | ||
ROIC |
(120.30%) | (54.52%) | (67.35%) | (40.41%) | |
Return on Tangible Assets |
(84.15%) | (158.08%) | (334.91%) | (49.00%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(0.42) | (0.63) | (0.40) | (0.40) | |
Free Cash Flow |
(2.58) | (3.07) | (4.33) | (5.46) | |
| Other line items | |||||
Cash ROIC |
(33.09%) | (19.11%) | (34.87%) | (14.49%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(397.61) | (555.17) | (694.36) | (959.42) | |
Operating CF/Net income |
0.62 | 0.51 | 0.59 | 0.63 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.42) | (0.63) | (0.40) | (0.40) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates